Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT

Seonghoon Jeong, Myonggeun Yoon, Weon Kuu Chung, Mijoo Chung, Dong Wook Kim

Research output: Contribution to journalArticle

Abstract

We developed and evaluated an algorithm to calculate the target radiation dose in cancer patients by measuring the transmitted dose during 3D conformal radiation treatment (3D-CRT) treatment. The patient target doses were calculated from the transit dose, which was measured using a glass dosimeter positioned 150 cm from the source. The accuracy of the transit dose algorithm was evaluated using a solid water phantom for five patient treatment plans. We performed transit dose-based patient dose verification during the actual treatment of 34 patients who underwent 3D-CRT. These included 17 patients with breast cancer, 11 with pelvic cancer, and 6 with other cancers. In the solid water phantom study, the difference between the transit dosimetry algorithm with the treatment planning system (TPS) and the measurement was −0.10 ± 1.93%. In the clinical study, this difference was 0.94 ± 4.13% for the patients with 17 breast cancers, −0.11 ± 3.50% for the eight with rectal cancer, 0.51 ± 5.10% for the four with bone cancer, and 0.91 ± 3.69% for the other five. These results suggest that transit-dosimetry-based in-room patient dose verification is a useful application for 3D-CRT. We expect that this technique will be widely applicable for patient safety in the treatment room through improvements in the transit dosimetry algorithm for complicated treatment techniques (including intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)).

Original languageEnglish
Pages (from-to)1571-1576
Number of pages6
JournalJournal of the Korean Physical Society
Volume73
Issue number10
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

transit
dosage
cancer
radiation
dosimeters
breast
rooms
water
bones
planning
radiation therapy
therapy
safety
arcs
glass

Keywords

  • 3D-CRT
  • Clinical test
  • Glass dosimeter
  • Transit dosimetry

ASJC Scopus subject areas

  • Physics and Astronomy(all)

Cite this

Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT. / Jeong, Seonghoon; Yoon, Myonggeun; Chung, Weon Kuu; Chung, Mijoo; Kim, Dong Wook.

In: Journal of the Korean Physical Society, Vol. 73, No. 10, 01.11.2018, p. 1571-1576.

Research output: Contribution to journalArticle

Jeong, Seonghoon ; Yoon, Myonggeun ; Chung, Weon Kuu ; Chung, Mijoo ; Kim, Dong Wook. / Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT. In: Journal of the Korean Physical Society. 2018 ; Vol. 73, No. 10. pp. 1571-1576.
@article{1f89c316491347e8b86d82d8c7c823e8,
title = "Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT",
abstract = "We developed and evaluated an algorithm to calculate the target radiation dose in cancer patients by measuring the transmitted dose during 3D conformal radiation treatment (3D-CRT) treatment. The patient target doses were calculated from the transit dose, which was measured using a glass dosimeter positioned 150 cm from the source. The accuracy of the transit dose algorithm was evaluated using a solid water phantom for five patient treatment plans. We performed transit dose-based patient dose verification during the actual treatment of 34 patients who underwent 3D-CRT. These included 17 patients with breast cancer, 11 with pelvic cancer, and 6 with other cancers. In the solid water phantom study, the difference between the transit dosimetry algorithm with the treatment planning system (TPS) and the measurement was −0.10 ± 1.93{\%}. In the clinical study, this difference was 0.94 ± 4.13{\%} for the patients with 17 breast cancers, −0.11 ± 3.50{\%} for the eight with rectal cancer, 0.51 ± 5.10{\%} for the four with bone cancer, and 0.91 ± 3.69{\%} for the other five. These results suggest that transit-dosimetry-based in-room patient dose verification is a useful application for 3D-CRT. We expect that this technique will be widely applicable for patient safety in the treatment room through improvements in the transit dosimetry algorithm for complicated treatment techniques (including intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)).",
keywords = "3D-CRT, Clinical test, Glass dosimeter, Transit dosimetry",
author = "Seonghoon Jeong and Myonggeun Yoon and Chung, {Weon Kuu} and Mijoo Chung and Kim, {Dong Wook}",
year = "2018",
month = "11",
day = "1",
doi = "10.3938/jkps.73.1571",
language = "English",
volume = "73",
pages = "1571--1576",
journal = "Journal of the Korean Physical Society",
issn = "0374-4884",
publisher = "Korean Physical Society",
number = "10",

}

TY - JOUR

T1 - Clinical Implementation of an In vivo Dose Verification System Based on a Transit Dose Calculation Tool for 3D-CRT

AU - Jeong, Seonghoon

AU - Yoon, Myonggeun

AU - Chung, Weon Kuu

AU - Chung, Mijoo

AU - Kim, Dong Wook

PY - 2018/11/1

Y1 - 2018/11/1

N2 - We developed and evaluated an algorithm to calculate the target radiation dose in cancer patients by measuring the transmitted dose during 3D conformal radiation treatment (3D-CRT) treatment. The patient target doses were calculated from the transit dose, which was measured using a glass dosimeter positioned 150 cm from the source. The accuracy of the transit dose algorithm was evaluated using a solid water phantom for five patient treatment plans. We performed transit dose-based patient dose verification during the actual treatment of 34 patients who underwent 3D-CRT. These included 17 patients with breast cancer, 11 with pelvic cancer, and 6 with other cancers. In the solid water phantom study, the difference between the transit dosimetry algorithm with the treatment planning system (TPS) and the measurement was −0.10 ± 1.93%. In the clinical study, this difference was 0.94 ± 4.13% for the patients with 17 breast cancers, −0.11 ± 3.50% for the eight with rectal cancer, 0.51 ± 5.10% for the four with bone cancer, and 0.91 ± 3.69% for the other five. These results suggest that transit-dosimetry-based in-room patient dose verification is a useful application for 3D-CRT. We expect that this technique will be widely applicable for patient safety in the treatment room through improvements in the transit dosimetry algorithm for complicated treatment techniques (including intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)).

AB - We developed and evaluated an algorithm to calculate the target radiation dose in cancer patients by measuring the transmitted dose during 3D conformal radiation treatment (3D-CRT) treatment. The patient target doses were calculated from the transit dose, which was measured using a glass dosimeter positioned 150 cm from the source. The accuracy of the transit dose algorithm was evaluated using a solid water phantom for five patient treatment plans. We performed transit dose-based patient dose verification during the actual treatment of 34 patients who underwent 3D-CRT. These included 17 patients with breast cancer, 11 with pelvic cancer, and 6 with other cancers. In the solid water phantom study, the difference between the transit dosimetry algorithm with the treatment planning system (TPS) and the measurement was −0.10 ± 1.93%. In the clinical study, this difference was 0.94 ± 4.13% for the patients with 17 breast cancers, −0.11 ± 3.50% for the eight with rectal cancer, 0.51 ± 5.10% for the four with bone cancer, and 0.91 ± 3.69% for the other five. These results suggest that transit-dosimetry-based in-room patient dose verification is a useful application for 3D-CRT. We expect that this technique will be widely applicable for patient safety in the treatment room through improvements in the transit dosimetry algorithm for complicated treatment techniques (including intensity modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT)).

KW - 3D-CRT

KW - Clinical test

KW - Glass dosimeter

KW - Transit dosimetry

UR - http://www.scopus.com/inward/record.url?scp=85057082907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057082907&partnerID=8YFLogxK

U2 - 10.3938/jkps.73.1571

DO - 10.3938/jkps.73.1571

M3 - Article

AN - SCOPUS:85057082907

VL - 73

SP - 1571

EP - 1576

JO - Journal of the Korean Physical Society

JF - Journal of the Korean Physical Society

SN - 0374-4884

IS - 10

ER -